Opus Genetics, Inc. Unrealized Gain (Loss) on Investments
Opus Genetics, Inc. (IRD) reported Unrealized Gain (Loss) on Investments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-06
- Opus Genetics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $0.00.
- Opus Genetics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was $0.00.
- Opus Genetics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $0.00.
- Opus Genetics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $0.00.
- Opus Genetics, Inc. unrealized gain (loss) on investments for fiscal 2025 was -$2.00K.
- Opus Genetics, Inc. unrealized gain (loss) on investments for fiscal 2024 was -$13.00K.
- Opus Genetics, Inc. unrealized gain (loss) on investments for fiscal 2023 was -$34.00K.
- Opus Genetics, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$170.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | -$1.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$1.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2026-08-06 | -$2.00K 10-Q · filed 2025-11-12 | -$3.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.00K 10-Q · filed 2026-08-06 | -$3.00K derived: sum of 3 quarters · filed 2026-08-06 | -$5.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.00K 10-Q · filed 2026-05-12 | -$2.00K derived: sum of 2 quarters · filed 2026-05-12 | -$4.00K derived: sum of 3 quarters · filed 2026-05-12 | -$4.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.00K derived: sum of 2 quarters · filed 2026-03-12 | -$3.00K derived: sum of 3 quarters · filed 2026-03-12 | -$13.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.00K derived: sum of 2 quarters · filed 2025-11-12 | -$12.00K 10-Q · filed 2025-11-12 | -$8.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$10.00K 10-Q · filed 2025-08-13 | -$6.00K derived: sum of 3 quarters · filed 2025-08-13 | -$17.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$10.00K 10-Q · filed 2025-05-15 | -$6.00K derived: sum of 2 quarters · filed 2025-05-15 | -$17.00K derived: sum of 3 quarters · filed 2025-05-15 | -$17.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$7.00K derived: sum of 2 quarters · filed 2025-03-31 | -$7.00K derived: sum of 3 quarters · filed 2025-03-31 | -$34.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$11.00K derived: sum of 2 quarters · filed 2024-11-12 | -$38.00K 10-Q · filed 2024-11-12 | -$90.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$27.00K 10-Q · filed 2024-08-13 | -$79.00K derived: sum of 3 quarters · filed 2024-08-13 | -$104.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$27.00K 10-Q · filed 2024-05-10 | -$79.00K derived: sum of 2 quarters · filed 2024-05-10 | -$104.00K derived: sum of 3 quarters · filed 2024-05-10 | -$113.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$77.00K derived: sum of 2 quarters · filed 2024-03-08 | -$86.00K derived: sum of 3 quarters · filed 2024-03-08 | -$170.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$34.00K derived: sum of 2 quarters · filed 2023-11-13 | -$118.00K 10-Q · filed 2023-11-13 | -$282.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$93.00K 10-Q · filed 2023-08-11 | -$257.00K derived: sum of 3 quarters · filed 2023-08-11 | -$163.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$84.00K 10-Q · filed 2023-05-15 | -$248.00K derived: sum of 2 quarters · filed 2023-05-15 | -$154.00K derived: sum of 3 quarters · filed 2023-05-15 | -$154.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$70.00K derived: sum of 2 quarters · filed 2023-03-30 | -$70.00K derived: sum of 3 quarters · filed 2023-03-30 | -$70.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $94.00K derived: sum of 2 quarters · filed 2022-11-04 | $94.00K 10-Q · filed 2022-11-04 | $94.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |